NKG2D Negatively Regulates CD4 T Cells in Allo-Response in Mice

Mengmeng Zhang,Yongxia Wu,David Bastian,Hung D. Nguyen,Supinya Iamsawat,Anusara Daenthanasanmak,Fangping Chen,Xue-Zhong Yu
DOI: https://doi.org/10.1182/blood.v130.suppl_1.2279.2279
IF: 20.3
2017-01-01
Blood
Abstract:NKG2D is a C-type lectin-like receptor which mainly expresses on mouse NK, activated CD8 and some γδ T cells. NKG2D is also found to express on human and mouse CD4 T cells, but the role of NKG2D in CD4 T cells is essentially unknown. We asked what subsets of CD4 T cells could express NKG2D; we activated and polarized CD4 T cells into Th0, Th1,Th2, Th17 and Foxp3+ Tregs in vitro and measured NKG2D expression on those subsets. We found that only a proportion of Th1 cells expressed NKG2D, whereas little or no NKG2D was expressed on other subsets of T cells. In a mixed lymphocyte reaction (MLR) assay, NKG2D was induced on a subset of CD4 T cells after stimulation with allogeneic antigen presenting cells (APCs) (Figure 1A). NKG2D+CD4+ T cells expressed higher levels of LAG-3, CD49b, CD80, FasL and PD-L1 (Figure 1B) and secreted more IL-10 and IFN-γ than NKG2D- CD4+ T cells (Figure 1C).
What problem does this paper attempt to address?